AIM: To determine whether ischemic preconditioning (IP) affects the development of edematous cerulein-induced pancreatitis and to assess the role of cyclooxygenase-1 (COX-1), COX-2, and heat shock protein 70 (HSP 70) in this process. METHODS: In male Wistar rats, IP was performed by clamping of celiac artery (twice for 5 min at 5-min intervals). Thirty minutes after IP or sham operation, acute pancreatitis was induced by cerulein. Activity of COX-1 or COX-2 was inhibited by resveratrol or rofecoxib, respectively (10 mg/kg). RESULTS: IP significantly reduced pancreatic damage in cerulein-induced pancreatitis as demonstrated by the improvement of pancreas histology, reduction in serum lipase and poly-C ribonuclease activity, and serum concentration of pro-inflammatory interleukin (IL)-1beta. Also, IP attenuated the pancreatitis-evoked fall in pancreatic blood flow and pancreatic DNA synthesis. Serum level of anti-inflammatory IL-10 was not affected by IP. Cerulein-induced pancreatitis and IP increased the content of HSP 70 in the pancreas. Maximal increase in HSP 70 was observed when IP was combined with cerulein-induced pancreatitis. Inhibition of COXs, especially COX-2, reduced the protective effect of IP in edematous pancreatitis. CONCLUSION: Our results indicate that IP reduces pancreatic damage in cerulein-induced pancreatitis and this effect, at least in part, depends on the activity of COXs and pancreatic production of HSP 70.
AIM: To determine whether ischemic preconditioning (IP) affects the development of edematous cerulein-induced pancreatitis and to assess the role of cyclooxygenase-1 (COX-1), COX-2, and heat shock protein 70 (HSP 70) in this process. METHODS: In male Wistar rats, IP was performed by clamping of celiac artery (twice for 5 min at 5-min intervals). Thirty minutes after IP or sham operation, acute pancreatitis was induced by cerulein. Activity of COX-1 or COX-2 was inhibited by resveratrol or rofecoxib, respectively (10 mg/kg). RESULTS: IP significantly reduced pancreatic damage in cerulein-induced pancreatitis as demonstrated by the improvement of pancreas histology, reduction in serum lipase and poly-C ribonuclease activity, and serum concentration of pro-inflammatory interleukin (IL)-1beta. Also, IP attenuated the pancreatitis-evoked fall in pancreatic blood flow and pancreatic DNA synthesis. Serum level of anti-inflammatory IL-10 was not affected by IP. Cerulein-induced pancreatitis and IP increased the content of HSP 70 in the pancreas. Maximal increase in HSP 70 was observed when IP was combined with cerulein-induced pancreatitis. Inhibition of COXs, especially COX-2, reduced the protective effect of IP in edematous pancreatitis. CONCLUSION: Our results indicate that IP reduces pancreatic damage in cerulein-induced pancreatitis and this effect, at least in part, depends on the activity of COXs and pancreatic production of HSP 70.
Authors: A C Wagner; H Weber; L Jonas; H Nizze; M Strowski; F Fiedler; H Printz; H Steffen; B Göke Journal: Gastroenterology Date: 1996-11 Impact factor: 22.682
Authors: S J Konturek; A Dembinski; P J Konturek; Z Warzecha; J Jaworek; P Gustaw; R Tomaszewska; J Stachura Journal: Gut Date: 1992-09 Impact factor: 23.059
Authors: Zygmunt Warzecha; Artur Dembiński; Piotr Ceranowicz; Stanisław Konturek; Romana Tomaszewska; Jerzy Stachura; Toshikazu Nakamura; Peter C Konturek Journal: Eur J Pharmacol Date: 2004-02-13 Impact factor: 4.432
Authors: Nirav G Shah; Mohan E Tulapurkar; Ishwar S Singh; James H Shelhamer; Mark J Cowan; Jeffrey D Hasday Journal: Prostaglandins Other Lipid Mediat Date: 2010-04-09 Impact factor: 3.072
Authors: Matthew C Koopmann; Megan D Baumler; Christopher J Boehler; Faye L Chang; Denise M Ney; Guy E Groblewski Journal: Pancreas Date: 2010-04 Impact factor: 3.327
Authors: Joanna Bonior; Zygmunt Warzecha; Piotr Ceranowicz; Ryszard Gajdosz; Piotr Pierzchalski; Michalina Kot; Anna Leja-Szpak; Katarzyna Nawrot-Porąbka; Paweł Link-Lenczowski; Michał Pędziwiatr; Rafał Olszanecki; Krzysztof Bartuś; Rafał Trąbka; Beata Kuśnierz-Cabala; Artur Dembiński; Jolanta Jaworek Journal: Int J Mol Sci Date: 2017-06-30 Impact factor: 5.923